Testing a protective pouch for insulin-producing cells in type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This early-stage trial tests a new 'immune-protected' pouch that holds insulin-making cells (islets) to treat type 1 diabetes. Some people also get a standard islet transplant, while others receive just the pouch. The purpose is to see if the pouch is safe and can help control blood sugar without requiring strong immune-suppressing drugs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have type 1 diabetes.
- You should be eligible for a standard islet cell transplant (Cohort A) or be part of a care team that approves this new device without transplant (Cohort B).
- Your eligibility follows your hospital's usual rules or your doctor's medical guidelines.
- You must be willing to have your medical records checked by the study team.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment made from pig pancreatic cells (called OPF-310) that are placed under the skin to help control blood sugar in people with type 1 diabetes. It is for those whose diabetes is difficult to manage and who have dangerous low blood sugar episodes.
This Phase 1/2 study tests whether CELZ-201 is safe and can help the body keep making some of its own insulin in people who were recently diagnosed with type 1 diabetes. You may be eligible if your diabetes started within the past year and your tests show you still have some insulin-making activity.
This study tests a smart insulin pump system that adjusts automatically during exercise. It aims to make managing blood sugar easier and safer.
This study tests a new way to give insulin directly into the abdomen (intraperitoneal) for people with type 1 diabetes. It will check how safe and effective a single dose is over 12 hours, using a special procedure to keep blood sugar stable (clamp).
This Phase 1 study tests a new immune-system strategy around islet transplantation (or donor bone marrow therapy) to improve control of type 1 diabetes and reduce dangerous low blood sugar. It mainly aims to see if the approach is safe and helpful in people with long-standing, difficult-to-manage diabetes.
This study tests a new treatment called E-islet 01, which may help people with type 1 diabetes who have very low natural insulin production and have had dangerous low blood sugar events. The goal is to see if it is safe and can reduce those episodes.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.